[Lung function test for COPD].

Shigeru Itabashi

Home/Archive/PubMed

PubMed · 14674325

[Lung function test for COPD].

Shigeru Itabashi

View original source ↗Export metadata ↓

Abstract

According to the guideline presented by Global Initiative for Chronic Obstructive Lung Disease(GOLD), the diagnosis of chronic obstructive pulmonary disease (COPD) has been simplified. COPD is diagnosed when FEV1(forced expiratory volume in one second)/FVC(forced vital capacity) is less than 70% (except Stage 0), and also the severity of disease is classified by FEV1. In this article, spirometry, a screening test for COPD, is explained at first, and then further examination to understand the pathophysiology of COPD is discussed. For management and following-up of COPD, both lung function test and arterial blood gas analysis are important.

Explore related subjects

Blood Gas Analysis Follow-Up Studies Forced Expiratory Volume Humans Mass Screening Practice Guidelines as Topic Pulmonary Disease, Chronic Obstructive Respiratory Function Tests Severity of Illness Index Spirometry Vital Capacity English Abstract Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Shigeru Itabashi. 2003. [Lung function test for COPD].. https://pubmed.ncbi.nlm.nih.gov/14674325/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Brain tissue oxygenation index measured by near infrared spatially resolved spectroscopy agreed with jugular bulb oxygen saturation in normal pediatric brain: a pilot study.

OBJECTIVES: This observational, prospective pediatric human study was performed to determine the agreement between brain tissue oxygenation indices (TOI) measured by near infrared spatially resolved spectroscopy and jugular bulb oxygen saturation values (SjO(2)). METHODS: Five cardiac patients without neurological impairment who were admitted into the critical care unit after open-heart surgery with jugular bulb venous catheters were enrolled. Their mean age was 8.6 months and mean body weight was 6.7 kg. Simultaneous measurements of brain TOI using NIR0-300 (Hamamatsu Photonics, Hamamatsu City, Japan) and SjO(2) values from blood samples were recorded. RESULTS: The TOI range was 59+/-9% and the SjO(2) range was 58+/-17%. The correlation coefficient R was 0.64 (p=0.11; n=14). Bland-Altman plotting revealed a bias of -3.4%, and precision of 7.2% (n=14). Intra-class correlation reliability analysis showed kappa of 0.55. CONCLUSION: Statistically, brain TOI was in reasonable agreement with SjO(2) in pediatric patients with normal brain within the measurement range from 50 to 70%.

Blood Gas Analysis↗

PubMed2005

[Perioperative evaluation of lung function].

Respiratory diseases contribute significantly to perioperative morbidity and mortality. Severe pulmonary complications usually emerge postoperatively. To minimise pulmonary risk, the perioperative evaluation of lung function is of major significance, allowing the identification of patient and surgery-related risk factors. In particular, the significance of the intraoperative assessment of lung function has gained in importance over the last few years. The following article describes the possibilities and frontiers of the perioperative assessment of lung function, and focuses especially on the significance of preoperative pulmonary function tests and the intraoperative interpretation of respiratory pressure, flow, and volume loops.

Blood Gas Analysis↗

PubMed2005

Is there an advantage of using pressure support ventilation with volume guarantee in the initial management of premature infants with respiratory distress syndrome? A pilot study.

OBJECTIVE: To evaluate the feasibility of using the pressure support ventilation with volume guarantee (PSV-VG) as an initial ventilatory mode in preterm infants with respiratory distress syndrome (RDS) after surfactant treatment to achieve accelerated weaning of peak inspiratory pressure (PIP) and mean airway pressure (MAP). STUDY DESIGN: Initial 24-hour ventilatory parameters were compared in two groups of preterm infants managed by PSV-VG and the synchronized intermittent mandatory ventilation (SIMV) mode in a randomized controlled pilot study after surfactant treatment for RDS. A total of 16 babies were randomized to PSV-VG (1198+/-108 g [mean+/-SEM]; 27.9+/-0.6 weeks) and 18 babies to SIMV (birth weight 1055+/-77 g; gestational age 27.4+/-0.5 weeks). Repeated measures analysis of variance was used to compare serial values of PIP and MAP in the two groups. RESULTS: The PIP and MAP decreased over time (p<0.001) during the first 24 hours after surfactant administration in both groups but the decrease in MAP was faster in the SIMV group compared to PSV-VG group (p=0.035). The median numbers of blood gases during the first 24 hours were four and two in the SIMV and PSV-VG groups, respectively (p<0.001). The overall outcomes were not significantly different between the two groups. CONCLUSION: PSV-VG did not offer any ventilatory advantage over SIMV in the initial management of surfactant-treated premature newborns with RDS except for minimizing the number of blood gases.

Blood Gas Analysis↗